Development and validation of a nomogram superior to CHADS2 and CHA2DS2-VASc models for predicting left atrial

Shikun Sun1, Changsheng Ma1, Ying Li2

  • 1Department of Cardiology, The First Affiliated Hospital of Soochow University, Suzhou, China.

PubMed

Insights

This study developed a novel nomogram to predict left atrial appendage thrombus in atrial fibrillation patients, outperforming existing risk scores. The model identifies high-risk individuals for stroke, improving clinical decision-making.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Predictive Modeling

Background:

  • Atrial fibrillation (AF) is a common arrhythmia with stroke as its critical complication, often caused by left atrial appendage thrombus (LAAT).
  • Accurate identification of patients at high risk for LAAT is crucial for stroke prevention.

Purpose of the Study:

  • To construct and validate a nomogram model for predicting left atrial appendage (LAA) dense spontaneous echo contrast (SEC) and LAAT.
  • To compare the predictive performance of the novel nomogram against established risk stratification models (CHADS₂ and CHA₂DS₂-VASc).

Main Methods:

  • A retrospective analysis of 433 AF patients who underwent transesophageal echocardiography (TEE).
  • Logistic regression was used to identify independent predictors for LAA dense SEC/LAAT.
  • A nomogram was constructed and its performance evaluated using consistency, receiver operating characteristic (ROC), and decision curve analyses.

Main Results:

  • Female gender, elevated D-dimer, reduced left ventricular ejection fraction, reduced left atrial ejection fraction, and decreased left atrial reservoir strain rate were significant predictors of LAA dense SEC/LAAT.
  • The developed nomogram demonstrated high consistency (0.921) and calibrated consistency (0.903).
  • The nomogram significantly outperformed the CHADS₂ and CHA₂DS₂-VASc models in predicting LAA dense SEC/LAAT, showing superior net reclassification and integrated discrimination improvements.

Conclusions:

  • The novel nomogram offers excellent performance in predicting LAA dense SEC/LAAT in AF patients.
  • This tool provides a superior alternative to the CHADS₂ and CHA₂DS₂-VASc models for identifying high-risk individuals.
  • The nomogram can aid clinicians in more accurate stroke risk stratification and management for AF patients.
Abstract